Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phylogenomics of the African laminate-toothed rats (Rodentia, Muridae, Otomys) in the Eastern Afromontane Biodiversity Hotspot: three colonisation waves followed by allopatric diversification on sky islands.

Molecular phylogenetics and evolution·2026
Same author

Brief Cognitive Analytic Therapy (CAT)-Informed Reformulation for Young People With Eating Disorders: A Case Series.

Clinical psychology & psychotherapy·2025
Same author

"It's like I used to share a room with self-injury, but now it lives next door": Exploring experiences of naturalistic improvement in non-suicidal self-injury.

Psychology and psychotherapy·2024
Same author

A Brief Cognitive Analytic Therapy-Informed Approach for Young People That Have Self-Injured (CATCH-Y): A Case Series.

Clinical psychology & psychotherapy·2024
Same author

Impact of the COVID-19 pandemic on cardiology fellowship training in a sub-Saharan African training centre: an African perspective.

Cardiovascular journal of Africa·2023
Same author

Content and delivery preferences for information to support the management of high blood pressure.

Journal of human hypertension·2022

Related Experiment Video

Updated: May 26, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Factors affecting the aldosterone/renin ratio.

M Stowasser1, A H Ahmed, E Pimenta

  • 1Endocrine Hypertension Research Centre, University of Queensland School of Medicine, Greenslopes and Princess-Alexandra Hospitals, Brisbane, Australia. m.stowasser@uq.edu.au

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|December 8, 2011
PubMed
Summary
This summary is machine-generated.

The aldosterone/renin ratio (ARR) screening test for primary aldosteronism can yield inaccurate results. Various medications, physiological states, and patient factors can cause false positives or negatives, necessitating careful interpretation and confirmatory testing.

More Related Videos

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

Related Experiment Videos

Last Updated: May 26, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

Area of Science:

  • Endocrinology
  • Clinical Chemistry

Background:

  • The aldosterone/renin ratio (ARR) is a key screening tool for primary aldosteronism.
  • However, numerous factors can lead to inaccurate ARR results, impacting diagnosis.

Purpose of the Study:

  • To comprehensively review factors influencing the accuracy of the aldosterone/renin ratio (ARR) in screening for primary aldosteronism.
  • To provide guidance on optimizing ARR testing conditions and interpreting results.

Main Methods:

  • Literature review of factors affecting ARR.
  • Analysis of recent findings on medication, physiological, and demographic influences.
  • Discussion of pre-analytical and analytical considerations for ARR measurement.

Main Results:

  • Medications (diuretics, SSRIs, beta-blockers, NSAIDs) and conditions (hypokalemia, hypertension, renal dysfunction, age) can cause false negatives or positives.
  • Female sex, luteal phase, and specific oral contraceptives can affect ARR, particularly with direct renin assays.
  • Optimizing pre-test conditions (medication withdrawal, salt loading, posture, timing) improves test sensitivity.

Conclusions:

  • The ARR is a screening test requiring careful interpretation due to potential inaccuracies.
  • Understanding and mitigating interfering factors are crucial for reliable primary aldosteronism screening.
  • Advanced assays like LC-MS/MS may improve diagnostic accuracy.